Back to discover
Drug

Albuterol

In clinical development
Emerging researchLate-stage developmentRising momentum
Also known as Accuneb, Airet, Airsupra, Combivent+9 more

Accuneb, Airet, Airsupra, Combivent, DuoNeb, ProAir, ProAir HFA, Proventil, Salbutamol, Salbutamolum, Ventolin, Volmax, Albuterol Sulfate.

5
Research papers
10
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Lung Anatomic, Physiologic, and Inflammatory Changes With Chronic Exposure to Secondhand Tobacco Smoke

Clinical trial2026-06-04Results expected Q4 2026 · ClinicalTrials.gov

Ventilation and Perfusion in Individuals With Asthma

Clinical trial2026-05-05Results expected Q2 2028 · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Albuterol
Aliases & brands
AccunebAiretAirsupraCombiventDuoNebProAirProAir HFAProventilSalbutamolSalbutamolumVentolinVolmaxAlbuterol Sulfate
RxNorm CUI
435
ChEMBL ID
CHEMBL714
UNII
QF8SVZ843E

Clinical trials

169 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
169
registered trials across all phases
LATEST COMPLETION 2026
10
Active studies
6
Recruiting
128
Late-stage (III+)
117
Completed
42
Discontinued
PHASE DISTRIBUTIONn = 169
Early Phase 13Phase 118Phase 1 / 21Phase 219Phase 2 / 33Phase 332Phase 445Phase N / A48

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

5 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20082013
Most influential
Recent papers
Major research themes1
Models, Theoretical1
Journals, researchers & institutions
Top journals
  • Chest1
  • Lancet (London, England)1
  • Pharmacotherapy1
  • Pulmonary pharmacology & therapeutics1
  • The Lancet. Respiratory medicine1
Leading researchers
  • Foxx-Lupo WT2
  • Morgan WJ2
  • Patanwala AE2
  • Snyder EM2
  • Wheatley CM2
  • Bacharier LB1
  • Bade E1
  • Baronio R1
Leading institutions
free-text, unnormalised
  • University of Arizona2
  • Arizona Respiratory Center1
  • Center for Clinical Pediatric Pharmacology Research1
  • College of Pharmacy1
  • University of Ferrara1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials